BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1874 related articles for article (PubMed ID: 14557170)

  • 1. Evaluation of the clinical course of dry eye syndrome.
    Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM
    Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD).
    Cuevas M; González-García MJ; Castellanos E; Quispaya R; Parra Pde L; Fernández I; Calonge M
    Curr Eye Res; 2012 Oct; 37(10):855-63. PubMed ID: 22632103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation.
    Pflugfelder SC; Tseng SC; Sanabria O; Kell H; Garcia CG; Felix C; Feuer W; Reis BL
    Cornea; 1998 Jan; 17(1):38-56. PubMed ID: 9436879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
    Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial.
    Burgess PI; Koay P; Clark P
    Cornea; 2008 May; 27(4):391-4. PubMed ID: 18434839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lid margins: sensitivity, staining, meibomian gland dysfunction, and symptoms.
    Golebiowski B; Chim K; So J; Jalbert I
    Optom Vis Sci; 2012 Oct; 89(10):1443-9. PubMed ID: 22922778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in singapore.
    Tong L; Chaurasia SS; Mehta JS; Beuerman RW
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3449-54. PubMed ID: 20181848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
    Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
    Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of aniridia and dry eyes.
    Jastaneiah S; Al-Rajhi AA
    Ophthalmology; 2005 Sep; 112(9):1535-40. PubMed ID: 16023212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Measurement of Tear Film Dynamics and Lipid Layer Thickness for Assessment of Non-Sjögren Dry Eye Syndrome With Meibomian Gland Dysfunction.
    Ji YW; Lee J; Lee H; Seo KY; Kim EK; Kim TI
    Cornea; 2017 Feb; 36(2):176-182. PubMed ID: 28060064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction.
    Albietz JM; Schmid KL
    Clin Exp Optom; 2018 Jan; 101(1):23-33. PubMed ID: 28585267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of vital staining and its correlation with aqueous tear deficiency and meibomian gland dropout.
    Uchiyama E; Aronowicz JD; Butovich IA; McCulley JP
    Eye Contact Lens; 2007 Jul; 33(4):177-9. PubMed ID: 17630624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A standardized visual scale for evaluation of tear fluorescein clearance.
    Macri A; Rolando M; Pflugfelder S
    Ophthalmology; 2000 Jul; 107(7):1338-43. PubMed ID: 10889108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
    Prabhasawat P; Tesavibul N; Mahawong W
    Cornea; 2012 Dec; 31(12):1386-93. PubMed ID: 23135530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meibomian gland dropout in patients with dry eye disease in China.
    Feng Y; Gao Z; Feng K; Qu H; Hong J
    Curr Eye Res; 2014 Oct; 39(10):965-72. PubMed ID: 25051400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meibomian gland dysfunction in patients with Sjögren syndrome.
    Shimazaki J; Goto E; Ono M; Shimmura S; Tsubota K
    Ophthalmology; 1998 Aug; 105(8):1485-8. PubMed ID: 9709762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The repeatability of clinical measurements of dry eye.
    Nichols KK; Mitchell GL; Zadnik K
    Cornea; 2004 Apr; 23(3):272-85. PubMed ID: 15084861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Autologous Serum Eye Drops Combined With Punctal Plugs for the Treatment of Sjögren Syndrome-Related Dry Eye.
    Liu Y; Hirayama M; Cui X; Connell S; Kawakita T; Tsubota K
    Cornea; 2015 Oct; 34(10):1214-20. PubMed ID: 26226470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months.
    Greiner JV
    Curr Eye Res; 2012 Apr; 37(4):272-8. PubMed ID: 22324772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.